NCT00280202Recruiting
Detection of Genetic Markers of Lung Cancer
Detection of Genetic Markers of Lung Cancer Initiation and Progression
Source: ClinicalTrials.gov · Last updated 24 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 6000 (estimated)
- First submitted
- 18 Jan 2006
- Start date
- Jun 1996
- Primary completion date
- Dec 2050
- Lead sponsor
- University of Pittsburgh
- Diseases
- Lung cancer
- NCT number
- NCT00280202
What you commit to
- Study type: Observational
- Planned participants: 6000
- From Jun 1996 to the primary completion date, Dec 2050
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Histologic confirmation of lung cancer, lung metastases from a primary site other than lung, mesothelioma or a radiographic lesion highly suspicious for malignancy
- Written informed consent.
- To be scheduled for a biopsy or surgical resection or have already had a biopsy and/or surgical removal of a lung mass
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hillman Cancer Center Coordinator of this site? Confirm its status | Pittsburgh | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.